Osteoarthritis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Osteoarthritis stocks.

Osteoarthritis Stocks Recent News

Date Stock Title
May 31 SNY FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31 SNY FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
May 31 SNY Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
May 31 SNY Regeneron/ Sanofi say FDA has delayed Dupixent COPD label
May 31 SNY Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
May 31 SNY Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
May 31 SNY Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
May 31 SNY Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
May 31 SNY Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
May 30 SNY Press Release: Sanofi completes acquisition of Inhibrx, Inc.
May 29 SNY VeeCon 2024 Speakers Announced: X CEO Linda Yaccarino, Content Creator Khaby Lame, Gary Vee Among Special Guests To Appear At Festival That Combines Business, Pop Culture, Web3
May 29 SNY Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
May 29 SNY 3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield
May 28 SNY FDA accepts Sanofi’s Sarclisa sBLA for priority review
May 27 SNY Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
May 27 SNY Sanofi's Sarclisa gets accepted for FDA priority review for treatment of multiple myeloma
May 27 SNY Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma
Osteoarthritis

Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.Causes include previous joint injury, abnormal joint or limb development, and inherited factors. Risk is greater in those who are overweight, have one leg of a different length, and have jobs that result in high levels of joint stress. Osteoarthritis is believed to be caused by mechanical stress on the joint and low grade inflammatory processes. It develops as cartilage is lost and the underlying bone becomes affected. As pain may make it difficult to exercise, muscle loss may occur. Diagnosis is typically based on signs and symptoms, with medical imaging and other tests occasionally used to either support or rule out other problems. In contrast to rheumatoid arthritis, which is primarily an inflammatory condition, in osteoarthritis, the joints do not become hot or red.Treatment includes exercise, efforts to decrease joint stress, support groups, and pain medications. Efforts to decrease joint stress include resting and the use of a cane. Weight loss may help in those who are overweight. Pain medications may include paracetamol (acetaminophen) as well as NSAIDs such as naproxen or ibuprofen. Long-term opioid use is generally discouraged due to lack of information on benefits as well as risks of addiction and other side effects. If pain interferes with normal life despite other treatments, joint replacement surgery may help. An artificial joint typically lasts 10 to 15 years.Osteoarthritis is the most common form of arthritis, affecting about 237 million (3.3% of the population). Among those over 60 years old, about 10% of males and 18% of females are affected. It is the cause of about 2% of years lived with disability. In Australia, about 1.9 million people are affected, and in the United States, 30 to 53 million people are affected. It becomes more common in both sexes as people become older.

Browse All Tags